Phosphorylated MARK4 was highly expressed in AD brain tissue, and it could phosphorylate tau at Ser262/356, contributing to tau accumulation, toxicity, and subsequent neurodegeneration (Oba et al., 2020; Waseem et al., 2021). This evidence concerns the gene MAPT and Alzheimer disease.